Corrigendum to “ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation”

Corrigendum to “ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation”

Saved in:

Bibliographic Details
Main Authors:	Ruiping Cao, Dian Fang, Jiahui Wang, Ying Yu, Hongwei Ye, Pinfang Kang, Zhenghong Li, Hongju Wang, Qin Gao
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2021/9813687
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation
by: Ruiping Cao, et al.
Published: (2019-01-01)

Targeting NLRP3 Inflammasome Alleviates Synovitis by Reducing Pyroptosis in Rats with Experimental Temporomandibular Joint Osteoarthritis
by: Yinzi Xin, et al.
Published: (2022-01-01)

Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
by: Cao R, et al.
Published: (2025-02-01)

High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells
by: Hong Feng, et al.
Published: (2016-01-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

RIPK2-Mediated Autophagy and Negatively Regulated ROS-NLRP3 Inflammasome Signaling in GMCs Stimulated with High Glucose
by: Chenlin Gao, et al.
Published: (2019-01-01)

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01)

Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
by: Keren Zhou, et al.
Published: (2016-01-01)

NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration
by: Jiangyuan Gao, et al.
Published: (2015-01-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

NLRP3 Inflammasome Activation Is Involved in Geniposide-Induced Hepatotoxicity
by: Yixuan Liu, et al.
Published: (2025-01-01)

Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis
by: Yan Fu, et al.
Published: (2021-01-01)

Trimethylamine-N-Oxide Promotes High-Glucose-Induced Dysfunction and NLRP3 Inflammasome Activation in Retinal Microvascular Endothelial Cells
by: Lidan Xue, et al.
Published: (2023-01-01)

Corrigendum to “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”
by: Jing Zhao, et al.
Published: (2019-01-01)

Verbascoside Inhibits the Activation of NLRP3 Inflammasome and Improves BV-2 Cell Inflammatory Damage
by: Wenjing HUANG, et al.
Published: (2025-02-01)

Artificially Cultivated Ophiocordyceps sinensis Alleviates Diabetic Nephropathy and Its Podocyte Injury via Inhibiting P2X7R Expression and NLRP3 Inflammasome Activation
by: Chao Wang, et al.
Published: (2018-01-01)

Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis
by: Yingnan Hu, et al.
Published: (2025-01-01)

Hydrogen-Rich Saline Inhibits NLRP3 Inflammasome Activation and Attenuates Experimental Acute Pancreatitis in Mice
by: Jian-Dong Ren, et al.
Published: (2014-01-01)

Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
by: Qiang Su, et al.
Published: (2021-01-01)

The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
by: Elisa Benetti, et al.
Published: (2013-01-01)

Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in Mice
by: Jie Yan, et al.
Published: (2019-01-01)

ROS-Mediated NLRP3 Inflammasome Activity Is Essential for Burn-Induced Acute Lung Injury
by: Shichao Han, et al.
Published: (2015-01-01)

Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production
by: József Tőzsér, et al.
Published: (2016-01-01)

The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review
by: Arezina Kasti, et al.
Published: (2025-01-01)

Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway
by: Dacheng Wu, et al.
Published: (2018-01-01)

VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy.
by: Huaji Jiang, et al.
Published: (2025-02-01)

NLRP3 Inflammasome Simultaneously Involved in Autophagy and Phagocytosis of THP-1 Cells to Clear Aged Erythrocytes
by: Qin Li, et al.
Published: (2022-01-01)

5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation
by: Jinque Luo, et al.
Published: (2025-01-01)

Ginsenoside Rd protects against acute liver injury by regulating the autophagy NLRP3 inflammasome pathway
by: Xiaomei Zhong, et al.
Published: (2025-01-01)

NLRP3 Inflammasome Expression in Gingival Crevicular Fluid of Patients with Periodontitis and Chronic Hepatitis C
by: Petra Surlin, et al.
Published: (2021-01-01)

Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy
by: Wenli Zhao, et al.
Published: (2022-01-01)

Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
by: Rosalie Matico, et al.
Published: (2024-12-01)

Scropolioside B Inhibits IL-1β and Cytokines Expression through NF-κB and Inflammasome NLRP3 Pathways
by: Tiantian Zhu, et al.
Published: (2014-01-01)

Hydroxysafflor Yellow A Inhibits LPS-Induced NLRP3 Inflammasome Activation via Binding to Xanthine Oxidase in Mouse RAW264.7 Macrophages
by: Xiaolong Xu, et al.
Published: (2016-01-01)

Methyl Canthin-6-one-2-carboxylate Inhibits the Activation of the NLRP3 Inflammasome in Synovial Macrophages by Upregulating Nrf2 Expression
by: Yuanyuan Chen, et al.
Published: (2025-01-01)

The ABC transporter A7 modulates neuroinflammation via NLRP3 inflammasome in Alzheimer’s disease mice
by: Irene Santos-García, et al.
Published: (2025-01-01)

HSF1 Alleviates Brain Injury by Inhibiting NLRP3-Induced Pyroptosis in a Sepsis Model
by: Yi-fu He, et al.
Published: (2023-01-01)

Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes
by: Zhen Qiu, et al.
Published: (2019-01-01)

MCL Plays an Anti-Inflammatory Role in Mycobacterium tuberculosis-Induced Immune Response by Inhibiting NF-κB and NLRP3 Inflammasome Activation
by: Qingwen Zhang, et al.
Published: (2017-01-01)

Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation
by: Lin Liao, et al.
Published: (2024-12-01)